Technology Clinical Trial
Official title:
Therapeutic Effectiveness of PARO Companion Robot for Elderly With Mild Cognitive Impairment/Dementia in Elderly Residential Setting: A Quasi-experimental Study
Verified date | March 2023 |
Source | The University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main trial is a 2-group quasi-experimental trial of comparing the outcome indicators between joining and not joining the 10-week personal assistive robot (PARO) training program in residents with dementia or mild cognitive impairment (MCI). The study questions are as follows: Primary study questions: i. Can participation of the 10-week PARO training program reduce neuropsychiatric symptoms at week 10? ii. Can participation of the 10-week PARO training program reduce loneliness at week 10? Secondary study questions: iii. Can participation of PARO training session reduce pulse rate (as an indicator of stress and anxiety)? iv. Can participation of PARO training session improve oxygen saturation (as an indicator of stress and anxiety)? v. What are the participants' emotions and engagement in PARO training sessions? Auxiliary study questions: vi. Can participation of the 10-week PARO training program reduce neuropsychiatric symptoms at week 14? vii. Can participation of the 10-week PARO training program reduce loneliness at week 14? viii. Can participation of the 10-week PARO training program improve quality of life at week 10? ix. Can participation of the 10-week PARO training program improve quality of life at week 14? x. Can participation of the 10-week PARO training program improve sleep quality at week 10? xi. Can participation of the 10-week PARO training program improve sleep quality at week 14? xii. Can participation of the 10-week PARO training program improve cognitive functioning at week 10? xiii. Can participation of the 10-week PARO training program improve cognitive functioning at week 14? xiv. What are the feelings, satisfaction, and acceptance of PARO of the participants and PARO facilitators?
Status | Completed |
Enrollment | 37 |
Est. completion date | October 13, 2022 |
Est. primary completion date | September 9, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria for residents in main trial: - Is diagnosed with mild to moderate dementia by doctors - Score at least 5 (Pan et al., 2020) and lower than the norm-derived age and education adjusted cutoff scores 7th percentile in HK-MoCA (Wong et al., 2015), non-dementia patients Exclusion Criteria for residents in main trial: - Have unstable physical or psychological conditions as advised by doctors or nurse in charge - Have severe medical conditions which limit the ability to participate in the PARO sessions - Have visual or hearing impairment that interfere with cognitive intervention - Fear or reluctance in using robots - Unable to communicate Inclusion Criteria for residents in qualitative interviews: - Have participated in the main trial - Able to verbally communicate in Cantonese as perceived by the staff of the related home Exclusion Criteria for residents in qualitative interviews: - None Inclusion Criteria of PARO facilitator for qualitative interviews: - Have participated in the main trial Exclusion Criteria for PARO facilitator in qualitative interviews: - None |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Haven of Hope Hang Hau Care and Attention Home for Severely Disabled | Hong Kong | |
Hong Kong | Haven of Hope Woo Ping Care & Attention Home | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong | Haven of Hope Hospital, The Social Innovation and Entrepreneurship Development Fund, Hong Kong |
Hong Kong,
Carmeli E. Aspects of assistive gerontechnology. Int J Disabil Hum Dev. 2009; 8(3): 215-218.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available. — View Citation
Jones C, Sung B, Moyle W. Engagement of a Person with Dementia Scale: Establishing content validity and psychometric properties. J Adv Nurs. 2018 May 17. doi: 10.1111/jan.13717. Online ahead of print. — View Citation
Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9. doi: 10.1176/jnp.12.2.233. — View Citation
Lawton MP, Van Haitsma K, Klapper J. Observed affect in nursing home residents with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 1996 Jan;51(1):P3-14. doi: 10.1093/geronb/51b.1.p3. — View Citation
Liu T, Lu S, Leung DKY, Sze LCY, Kwok WW, Tang JYM, Luo H, Lum TYS, Wong GHY. Adapting the UCLA 3-item loneliness scale for community-based depressive symptoms screening interview among older Chinese: a cross-sectional study. BMJ Open. 2020 Dec 10;10(12):e041921. doi: 10.1136/bmjopen-2020-041921. — View Citation
Morin CM. Insomnia: psychological assessment and management. Guilford press. 1993.
Pan IMY, Lau MS, Mak SC, Hariman KW, Hon SKH, Ching WK, Cheng KM, Chan CF. Staging of Dementia Severity With the Hong Kong Version of the Montreal Cognitive Assessment (HK-MoCA)'s. Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):333-338. doi: 10.1097/WAD.0000000000000399. — View Citation
Piau A, Campo E, Rumeau P, Vellas B, Nourhashemi F. Aging society and gerontechnology: a solution for an independent living? J Nutr Health Aging. 2014 Jan;18(1):97-112. doi: 10.1007/s12603-013-0356-5. — View Citation
Russell DW. UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess. 1996 Feb;66(1):20-40. doi: 10.1207/s15327752jpa6601_2. — View Citation
Wong A, Law LS, Liu W, Wang Z, Lo ES, Lau A, Wong LK, Mok VC. Montreal Cognitive Assessment: One Cutoff Never Fits All. Stroke. 2015 Dec;46(12):3547-50. doi: 10.1161/STROKEAHA.115.011226. Epub 2015 Oct 15. — View Citation
Wong ELY, Ramos-Goni JM, Cheung AWL, Wong AYK, Rivero-Arias O. Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong. Patient. 2018 Apr;11(2):235-247. doi: 10.1007/s40271-017-0278-0. — View Citation
Yu DS. Insomnia Severity Index: psychometric properties with Chinese community-dwelling older people. J Adv Nurs. 2010 Oct;66(10):2350-9. doi: 10.1111/j.1365-2648.2010.05394.x. Epub 2010 Aug 16. — View Citation
* Note: There are 13 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 10 week change in neuropsychiatric symptoms after participating in 10-week PARO training program | Change of neuropsychiatric symptoms after participating in 10-week PARO training program will be measured by Neuropsychiatric Inventory Questionnaire (NPI-Q; Cummings, et al., 1994; Kauffer, 1999). The range of the the severity scale is 12 to 36, with higher score indicating more severe neuropsychiatric symptoms. The range of the caregiver distress scale is 0 to 60, with higher score indicating higher caregiver distress. | Baseline and the 10th week | |
Primary | 10 week change in loneliness after participating in 10-week PARO training program | Change of loneliness after participating in 10-week PARO training program will be measured by UCLA Loneliness Scale 3 items (UCLA 3-items, Russell et al., 1980; Liu et al., 2020). The minimum and maximum values of the scale are 3 and 9 respectively, with higher score indicating higher level of loneliness. | Baseline and the 10th week | |
Secondary | Change in feelings of stress and anxiety as indicated by pulse rate after participating in PARO training session | The change of feelings of stress and anxiety after participating in PARO training session will be measured by pulse rate. | Before and after the three training sessions during the 10-week trial period | |
Secondary | Change in feelings of stress and anxiety as indicated by oxygen saturation after participating in PARO training session | The change of feelings of stress and anxiety after participating in PARO training session will be measured by oxygen saturation | Before and after the three training sessions during the 10-week trial period | |
Secondary | Qualitative Measure: Observed emotions | Emotions will serve as an indicator of satisfaction and acceptance of PARO, and will be observed in PARO training session using Observed Emotion Rating Scale (OERS; Lawton et al., 1999). Under the scale, the 5 emotions of pleasure, general alertness, anxiety/ fear, anger, and sadness are observed. The minimum and maximum values of each coding for 10 minutes observation are 1 and 5 respectively, with higher score indicating longer duration of the observed emotion within the 10 minute period. | 3 PARO training sessions during the 10-week trial period | |
Secondary | Qualitative Measure: Observed engagement | Engagement will serve as an indicator of satisfaction and acceptance of PARO. After each training session and free-play session, PARO facilitators will complete Engagement of a Person with Dementia Scale (EPDS; Jones et al., 2018) for every participant. The minimum and maximum values of EPDS are 10 and 50 respectively, with higher score indicating higher level of positive engagement exhibited. | Every PARO training session and every free-play session during the 10-week trial period | |
Secondary | Qualitative Measure: Observed engagement (compliance) | Compliance will serve as an indicator of engagement, satisfaction and acceptance of PARO. After each training session and free-play session, PARO facilitators will complete two items about compliance and non-compliance with instructions for every participant. The minimum and maximum values of the sum of the two items are 2 and 10 respectively, with higher score indicating higher compliance. | Every PARO training session during the 10-week trial period | |
Secondary | 14 week change in neuropsychiatric symptoms after participating in 10-week PARO training program | Change of neuropsychiatric symptoms after participating in 10-week PARO training program will be measured by Neuropsychiatric Inventory Questionnaire (NPI-Q; Cummings, et al., 1994; Kauffer, 1999). The range of the the severity scale is 12 to 36, with higher score indicating more severe neuropsychiatric symptoms. The range of the caregiver distress scale is 0 to 60, with higher score indicating higher caregiver distress. | Baseline and 14th week | |
Secondary | 14 week change in loneliness after participating in 10-week PARO training program | Change of loneliness after participating in 10-week PARO training program will be measured by UCLA Loneliness Scale 3 items (UCLA 3-items, Russell et al., 1980; Liu et al., 2020). The minimum and maximum values of the scale are 3 and 9 respectively, with higher score indicating higher level of loneliness. | Baseline and 14th week | |
Secondary | Change in quality of life after participating in 10-week PARO training program | The change of quality of life after participating in 10-week PARO training program will be measured by 5-level EQ-5D (EQ-5D-5L; Wong et al., 2018). Using the algorithm based on Hong Kong population, the minimum and maximum utility values of the scale are -0.803 and 1 respectively, with higher score indicating better quality of life. | Baseline, the 10th week and 14th week | |
Secondary | Change in sleep quality after participating in 10-week PARO training program | The change of sleep quality after participating in 10-week PARO training program will be measured by Insomnia Severity Index (ISI; Morin 1993; Yu, 2010). The minimum and maximum values of the scale are 0 and 16 respectively, with higher score indicating higher insomnia severity. | Baseline, the 10th week and 14th week | |
Secondary | Change in cognitive functions after participating in 10-week PARO training program | The change of cognitive functions of after participating in 10-week PARO training program will be measured by Mini-Mental State Examination (MMSE; Folstein et al., 1975). The minimum and maximum values of the scale are 0 and 30 respectively, with higher score indicating higher level of cognitive functioning. | Baseline, the 10th week and 14th week | |
Secondary | Qualitative Measure: Perceived feelings, satisfaction and acceptance on companion robot by the participants | The participants answer the following question in semi-structured qualitative interviews:
Do you like (the name of the robot)? What do you like about (the name of the robot)? Did (the name of the robot) do something you dislike? Is there anything you dislike about (the name of the robot)? How do you feel with the company of (the name of the robot)? What do you do with (the name of the robot) regularly? Do you wish to spend more time (the name of the robot)? Under what circumstances, do you need the company of (the name of the robot) Do you wish or need others to spend time with (the name of the robot) and you? To conclude, are you satisfied or dissatisfied with (the name of the robot)? Do you wish to see it again? |
within 2 weeks after week 10 | |
Secondary | Qualitative Measure: Perceived feelings, satisfaction and acceptance on companion robot by the PARO facilitators | The PARO facilitators answer the following questions in semi-structured qualitative interviews:
Were the companion robots safe? Was it easy or difficult to use the companion robots? Did you expect the participants to accept the companion robots? What types of participants are more likely and less likely to accept the companion robots? When are the participants more willing to interact with the companion robots? What do you suggest to improve the acceptability of the companion robots? Is the training on companion robots sufficient? What did you expect to be the benefits and concerns of the companion robots? Did you find these benefits and concerns? Were there any unexpected benefits and concerns? What are your suggestions to the staff who will use the companion robots? Are you satisfied or dissatisfied with the companion robots? Do you want to use the companion robots in the future? Are companion robots cost-effective? |
within 2 weeks after week 10 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03253406 -
Health Wearables and College Student Health
|
N/A | |
Completed |
NCT04187274 -
Evaluation of the IKORUS Technology in Patients Undergoing Major Abdominal Surgery
|
||
Recruiting |
NCT05785702 -
Anti-wandering System for People With Intellectual Disability
|
N/A | |
Recruiting |
NCT05615259 -
Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty
|
||
Completed |
NCT02914730 -
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
|
||
Recruiting |
NCT05621044 -
Physical Activity Smartphone App for African American Men (FitBros) Ph II
|
N/A | |
Completed |
NCT04121624 -
Evaluation of a Novel Mobile Phone Application ( OptiBP) for Blood Pressure Monitoring
|
||
Completed |
NCT03722667 -
Technology-based Intervention and Positive Psychological Training for Blood Pressure Control in African Americans
|
N/A | |
Completed |
NCT02583711 -
The Step Home Trial: Utilising Physical Activity Data in the Acute Post-operative Setting
|
||
Recruiting |
NCT05877586 -
CLARE Mobile App for Caregiver Training and Support
|
N/A | |
Completed |
NCT03305458 -
Improving Quality of Care in Child Mental Health Service Settings
|
N/A | |
Completed |
NCT03309787 -
Health Coaching & Technology in a Weight Loss Center
|
||
Not yet recruiting |
NCT06146868 -
Gerontechnology Evaluation Framework: Outcome Validation
|
||
Completed |
NCT04119193 -
Agreement and Precision of a Smartphone Application For Continuous Blood Pressure Monitoring
|
||
Completed |
NCT05385458 -
Acceptance and Commitment Therapy (ACT) Tele-Counselling
|
N/A | |
Enrolling by invitation |
NCT05572398 -
Online Bullying Bystander Intervention for Middle Schools Phase II
|
N/A | |
Completed |
NCT05302895 -
Efficiency of an All-in-one Health Monitoring Device in Elderly Residential Setting
|
||
Recruiting |
NCT06226285 -
Quality of Life for Carers Through a Person-Centred Technological Solution
|
N/A | |
Completed |
NCT05772949 -
Effectiveness of a Smart Hearing Aid on Improving Psychosocial Well-being in Elderly
|
N/A | |
Completed |
NCT05509712 -
Physical Activity Smartphone App for African American Men (FitBros) Phase I
|